Red Tape Reduction Must Be A Priority For New Health Minister
18th Jan 17
The peak business organisation representing manufacturers and suppliers of dental products, the Australian Dental Industry Association (ADIA), has welcomed the appointment of the Hon. Greg Hunt MP as Minister for Health. In doing so, ADIA has signalled an intent to work with the new Minister to cut the red tape associated with supplying dental products.
Key Issues For The Dental Industry —
Red tape abounds in the dental industry. For importers of products it can be a challenge to bring new and innovative products to market as Australian regulatory requirements differ to those of comparable overseas markets. ADIA looks forward to working with Mr Hunt (pictured above) to remove the unnecessary regulatory duplication that increases the cost and time associated with introducing new dental products to the Australian market.
A major priority for Mr Hunt should be to ensure that the Australian Government’s response to the review of medicines and medical device regulation is implemented in full and in a timely manner.
ADIA is a strong advocate for a regulatory framework for dental products that is based on a risk management approach designed to ensure public health and safety, while at the same time freeing industry from an unnecessary regulatory burden. The Australian Government’s proposed reforms go a long way to achieving this.
ADIA expects to provide a briefing to the new Minister when parliament reconvenes next month.
The Association has enjoyed working with Mr Hunt in the past. In the environment portfolio our engagement was on several issues associated with dental product supply. More recently, as Minister for Industry, Innovation and Science we were pleased to work with him on high-tech medical device manufacturing issues.
Member engagement —
ADIA is frequently engaged with members of the Australian Parliament. ADIA's work at a parliamentary level is designed to maintain amongst politicians ADIA’s status as a recognised source of sound advice and guidance. This achieved, ADIA is able to be an effective advocate for the reform objectives set out in ADIA’s policy statements.
Further Information —
To keep up to date on developments associated with this matter, follow ADIA on Facebook at www.facebook.com/dental.industry or subscribe to the Twitter feed @AusDental. Questions concerning this policy issue can be sent to email@example.com or you can telephone 1300 943 094.
Currency Of Information & Disclaimer —
This update was issued on 18 January 2017 and please note that changes in circumstances after the publication of material or information may impact upon its accuracy and also change regulatory compliance obligations. The statements, regulatory and technical information contained herein are believed to be accurate and are provided for information purposes only. Readers are responsible for assessing its relevance and verifying the accuracy of the content. To the fullest extent permitted by law, ADIA will not be liable for any loss, damage, cost or expense incurred in relation to or arising as a result of relying on the information presented here.
This publication is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, images and where stated.
6th Mar 19
The Therapeutic Goods Administration (TGA) has released an update on Brexit and the implications for therapeutic goods in Australia under any of the possible agreements that could occur.
10th Dec 18
The Australian Government has launched a new Action Plan to help Australian businesses tackle trade barriers, helping them to get their goods into overseas markets faster, with greater ease and at a lower cost.